Danske Bank’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.4K Hold
200
﹤0.01% 732
2026
Q1
$0 Sell
200
-200
-50% -$3.23K ﹤0.01% 1186
2025
Q4
$6.89K Hold
400
﹤0.01% 1344
2025
Q3
$10.3K Hold
400
﹤0.01% 1264
2025
Q2
$23K Hold
400
﹤0.01% 1159
2025
Q1
$43.3K Hold
400
﹤0.01% 964
2024
Q4
$19K Hold
400
﹤0.01% 1009
2024
Q3
$39.3K Buy
400
+200
+100% +$25.8K ﹤0.01% 1248
2024
Q2
$32.7K Hold
200
﹤0.01% 1013
2024
Q1
$30.5K Buy
+200
New +$33.3K ﹤0.01% 1009

Other funds holding AGL

Danske Bank's AGL Position: Q2 2026 in Review

Danske Bank held its Agilon Health (AGL) position steady in Q2 2026 at 200 shares worth $21.4K. The position accounts for ﹤0.01% of the portfolio, ranked #732.

Danske Bank first reported a position in AGL in Q1 2024 and has held it in 10 quarters since. The position peaked at $43.3K in Q1 2025. 111 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Danske Bank held 200 shares of Agilon Health worth $21.4K as of Q2 2026.
  • Danske Bank left its Agilon Health share count unchanged in Q2 2026.
  • Agilon Health made up ﹤0.01% of Danske Bank's portfolio in Q2 2026, its #732 holding.
  • Danske Bank first reported a position in Agilon Health in Q1 2024 and has held it in 10 quarters since.
  • Danske Bank's Agilon Health position peaked at $43.3K in Q1 2025.
  • 111 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Danske Bank's 13F filing for Q2 2026, filed 10 Aug 2026.